²é¿´: 773  |  »Ø¸´: 3

190824656

ľ³æ (ÕýʽдÊÖ)

[ÇóÖú] ΢Æ×Ç󻯺ÏÎï½á¹¹

CÆ×Êý¾Ý£¨CDCl3£©£º211.6, 170.2, 168.3, 140.7, 138.1, 131.7, 129.6, 129.2, 129.1, 127.1, 122.8, 86.9, 63.0, 56.3, 55.8, 51.9, 48.0, 43.7, 39.1, 35.7, 35.6, 34.6, 20.3, 18.9, 14.5, 11.9.
»Ø¸´´ËÂ¥

» ²ÂÄãϲ»¶

» ±¾Ö÷ÌâÏà¹Ø¼ÛÖµÌùÍÆ¼ö£¬¶ÔÄúͬÑùÓаïÖú:

ÒÑÔÄ   »Ø¸´´ËÂ¥   ¹Ø×¢TA ¸øTA·¢ÏûÏ¢ ËÍTAºì»¨ TAµÄ»ØÌû

wangkaibo123

ÈÙÓþ°æÖ÷ (Ö°Òµ×÷¼Ò)

kerry

ÓÅÐã°æÖ÷

Domyallbesttohaveahappylife.
2Â¥2013-06-28 13:33:58
ÒÑÔÄ   »Ø¸´´ËÂ¥   ¹Ø×¢TA ¸øTA·¢ÏûÏ¢ ËÍTAºì»¨ TAµÄ»ØÌû

190824656

ľ³æ (ÕýʽдÊÖ)

ÒýÓûØÌû:
2Â¥: Originally posted by wangkaibo123 at 2013-06-28 13:33:58
·´ÁË

11.9, 14.5, 18.9, 20.3, 34.6, 35.7, 39.1, 43.7, 48.0, 51.9, 55.8, 56.3, 63.0, 86.9, 122.8, 127.1, 129.1, 129.2, 129.6, 131.7, 138.1, 140.7, 168.3, 170.2, 211.6
3Â¥2013-06-28 13:46:59
ÒÑÔÄ   »Ø¸´´ËÂ¥   ¹Ø×¢TA ¸øTA·¢ÏûÏ¢ ËÍTAºì»¨ TAµÄ»ØÌû

wangkaibo123

ÈÙÓþ°æÖ÷ (Ö°Òµ×÷¼Ò)

kerry

ÓÅÐã°æÖ÷

¡¾´ð°¸¡¿Ó¦Öú»ØÌû

¡ï ¡ï ¡ï ¡ï ¡ï ¡ï ¡ï ¡ï ¡ï ¡ï ¡ï ¡ï ¡ï ¡ï ¡ï
¸Ðл²ÎÓ룬ӦÖúÖ¸Êý +1
190824656: ½ð±Ò+15 2013-06-28 17:26:25
°´´ÓСµ½´ó˳ÐòÊäÈ룬Êý×Ö¼äÓÃÓ¢Îİë½Ç¶ººÅ(,)·Ö¸ôÀýÈ磺
21.4,30.4,37.4,73.2,73.7,125.6,126.6,139.6,140.2,168.2

ÈܼÁÑ¡Ï
Æ¥ÅäÈݲ (Êý×Ö¸ñʽ£¬¿É×ÔÐÐÉ趨)
ÏàËÆ¶È£º   %(ÏàËÆ¶È>=50%)



²éѯ½á¹û£º¹²²éµ½186¸ö»¯ºÏÎï(²éѯ½á¹û½ö¹©²Î¿¼)
1 .     (2S)-N-[(1R,3RS)-3-((3R)-4,4-Dimethyl-2-oxo-tetrahydro-furan-3-yloxy)-3-methoxy-1-phenyl-propyl]-2-(1,3-dioxo-1,3-dihydroisoindol-2-yl)-3-phenyl-propionamide
C33H34N2O7     ÏàËÆ¶È:60%
Tetrahedron          2012          68          2179-2188
Access to C-protected ¦Â-amino-aldehydes via transacetalization of 6-alcoxy tetrahydrooxazinones and use for pseudo-peptide synthesis
Pavlo Shpak-Kraievskyi, Biaolin Yin, Arnaud Martel, Robert Dhal, Gilles Dujardin, Mathieu Y. Laurent
Structure      13C NMR   Ì¼Æ×Ä£Äâͼ
2 .     (S)-methyl 2-(2-(2-(N-((2'-(1H-tetrazol-5-yl)biphenyl-4-yl)methyl)pentanamido)-3-methylbutanamido)acetamido)-acetate
    ÏàËÆ¶È:60%
Archiv der Pharmazie          2012          345          393-400
Synthesis, Pharmacokinetics, and Pharmacodynamics Studies of Valsartan Peptide Derivatives
Chun Wu, Yanpeng Hu, Qianbin Li, Limei He, Jun Chen, Zeneng Cheng, Yuanjian Li and Gaoyun Hu
Structure      13C NMR   Ì¼Æ×Ä£Äâͼ
3 .     cytochalasin E
    ÏàËÆ¶È:57.6%
Journal of Natural Products          2006          69(6)          871-875
10-Phenyl-[12]-cytochalasins Z7, Z8, and Z9 from the Marine-Derived Fungus Spicaria elegans
Rui Liu, Qianqun Gu, Weiming Zhu, Chengbin Cui, Guotao Fan, Yuchun Fang, Tianjiao Zhu, and Hongbing Liu
Structure      13C NMR   Ì¼Æ×Ä£Äâͼ
4 .     cytochalasin E
    ÏàËÆ¶È:57.6%
Chemical & Pharmaceutical Bulletin          1989          37          2212-2213
Nuclear Magnetic Resonance Studies of Cytochalasin E and Its Decomposition Product
Tetsuya KAJIMOTO,Yohko IMAMURA,Masami YAMASHITA,Kokichi TAKAHASHI,Motoo SHIBATA and Toshihiro NOHARA
Structure      13C NMR   Ì¼Æ×Ä£Äâͼ
5 .     cytochalasin E
    ÏàËÆ¶È:57.6%
Agricultural and Biological Chemistry          1989          53          1699-1701
Structure of Rosellichalasin, a New Metabolite Produced by Rosellinia necatrix
Yasuo KIMURA, Hiromitsu NAKAJIMA, Takashi HAMASAKI
Structure      13C NMR   Ì¼Æ×Ä£Äâͼ
6 .     cytochalasin N
C30H37NO7     ÏàËÆ¶È:57.1%
Journal of the Chemical Society, Perkin Transactions 1          1989                   57-65
Metabolites of the higher fungi. Part 24. Cytochalasin N, O, P, Q, and R. New cytochalasins from the fungus Hypoxylon terricola Mill
Raymond L. Edwards, Derek J. Maitland and Anthony J. S. Whalley
Structure      13C NMR   Ì¼Æ×Ä£Äâͼ
7 .     ethyl ent-15¦Á-benzoyloxymethyl-16¦Â-hydroxybeyeran-19-oate
C30H42O5     ÏàËÆ¶È:56.6%
Bioorganic & Medicinal Chemistry          2009          17          1464-1473
Stereoselective synthesis of bioactive isosteviol derivatives as ¦Á-glucosidase inhibitors
Ya Wu, Jing-Hua Yang, Gui-Fu Dai, Cong-Jun Liu, Guo-Qiang Tian, Wen-Yan Ma, Jing-Chao Tao
Structure      13C NMR   Ì¼Æ×Ä£Äâͼ
8 .     (S)-N¦Á,N1,¦Â,¦Â-Tetramethyltryptophanyl-(S)-tert-leucyl-(2e)-N-methyl-4-amino-2-methylbut-2-enoic acid
C27H40N4O4     ÏàËÆ¶È:56%
Journal of Natural Products          2003          66          183-199
Synthesis and Antimitotic/Cytotoxic Activity of Hemiasterlin Analogues
James A. Nieman, John E. Coleman, Debra J. Wallace, Edward Piers, Lynette Y. Lim, Michel Roberge, and Raymond J. Andersen
Structure      13C NMR   Ì¼Æ×Ä£Äâͼ
9 .     ajugacumbine F
C25H38O7     ÏàËÆ¶È:56%
Chemical & Pharmaceutical Bulletin          1990          38          3167-3168
Two New neo-Clerodane Diterpenes in Ajuga decumbens
Zhi-da MIN,Mizuo MIZUNO,Shi-qiang WANG,Munekazu IINUMA and Toshiyuki TANAKA
Structure      13C NMR   Ì¼Æ×Ä£Äâͼ
10 .     1,3-Dibutyl-3,3a,5,9b-tetrahydro-9b-hydroxy-5-methyl-3a-phenyl-1H-imidazo[4,5-c]quinoline-2,4-dione
C25H31N3O3     ÏàËÆ¶È:56%
Helvetica Chimica Acta          2009          92          689-708
Molecular Rearrangement of 9b-Hydroxy-1H-imidazo[4,5-c]quinoline-2,4-diones - A Convenient Pathway to Spiro-Linked Imidazolidine-Oxindole Derivatives
Anton¨ªn Kl¨¢sek, Anton¨ªn Lyčka, Ivan Mikš¨ªk, Aleš Růička
Structure      13C NMR   Ì¼Æ×Ä£Äâͼ
11 .     ajugaciliatin J
C25H38O7     ÏàËÆ¶È:56%
Journal of Natural Products          2011          84          1575-1583
Bioactive neo-Clerodane Diterpenoids from the Whole Plants of Ajuga ciliata Bunge
Ping Guo,Yushan Li, Jing Xu, Cuizhou Liu,Yonggang Ma, and Yuanqiang Guo
Structure      13C NMR   Ì¼Æ×Ä£Äâͼ
12 .     (2R)-N-[(1R,3RS)-3-((3R)-4,4-Dimethyl-2-oxo-tetrahydro-furan-3-yloxy)-3-methoxy-1-phenyl-propyl]-2-(1,3-dioxo-1,3-dihydroisoindol-2-yl)-3-phenyl-propionamide
C33H34N2O7     ÏàËÆ¶È:56%
Tetrahedron          2012          68          2179-2188
Access to C-protected ¦Â-amino-aldehydes via transacetalization of 6-alcoxy tetrahydrooxazinones and use for pseudo-peptide synthesis
Pavlo Shpak-Kraievskyi, Biaolin Yin, Arnaud Martel, Robert Dhal, Gilles Dujardin, Mathieu Y. Laurent
Structure      13C NMR   Ì¼Æ×Ä£Äâͼ
13 .     2¦Â-(2-phenylethylamino)-5¦Á-androstane-3¦Á,17¦Â-diol
C27H41NO2     ÏàËÆ¶È:56%
Bioorganic & Medicinal Chemistry          2008          16          5062-5077
Chemical synthesis of 2¦Â-amino-5¦Á-androstane-3¦Á,17¦Â-diol N-derivatives and their antiproliferative effect on HL-60 human leukemia cells
Dominic Thibeault, Jenny Roy, Patrick DeRoy, Donald Poirier
Structure      13C NMR   Ì¼Æ×Ä£Äâͼ
14 .     UK-2B
C27H30N2O9     ÏàËÆ¶È:56%
The Journal of Antibiotics          1996          49          1226-1231
UK-2A, B, C and D, Novel Antifungal Antibiotics from Streptomyces sp. 517-02 II. Structural Elucidation
MUHAMMAD HANAFI, KOZO SHIBATA, MASASHI UEKI, MAKOTO TANIGUCHI
Structure      13C NMR   Ì¼Æ×Ä£Äâͼ
15 .     5-carboxamido-3-{N-[3-(4-cyano-4-phenylpiperidin-1-yl)propyl]carboxamido}-1,4-dihydro-2,6-dimethyl-4-(4-nitrophenyl)pyridine hydrochloride sesquihydrate
C30H34N6O4     ÏàËÆ¶È:56%
Journal of Medicinal Chemistry          1998          41          5320-5333
Design and Synthesis of Novel ¦Á1a Adrenoceptor-Selective Dihydropyridine Antagonists for the Treatment of Benign Prostatic Hyperplasia
Dhanapalan Nagarathnam, John M. Wetzel, Shou Wu Miao, Mohammad R. Marzabadi, George Chiu, Wai C. Wong, Xingfang Hong, James Fang, Carlos Forray, Theresa A. Branchek, William E. Heydorn, Raymond S. L. Chang, Theodore Broten, Terry W. Schorn, and Charles Gl
Structure      13C NMR   Ì¼Æ×Ä£Äâͼ
16 .     cis-N-tert-butyl-2-[3-(1-2-amino-3-phenylpropionamido)-2-oxo-5-phenyl-8-methyl-2,3,4,5-tetrahydro-1H-1-benzazepin-1-yl]ethanoic acid amide
    ÏàËÆ¶È:56%
Journal of Medicinal Chemistry          1994          37          3789-3811
5-Phenyl-3-ureidobenzazepin-2-ones as Cholecystokinin-B Receptor Antagonists
John A. Lowe III, David L. Hageman, Susan E. Drozda, Stafford McLean, Dianne K. Bryce, Rosemary T. Crawford, Stevin Zorn, Jean Morrone, Jon Bordner
Structure      13C NMR   Ì¼Æ×Ä£Äâͼ
17 .     trans-N-tert-butyl-2-[3-(1-2-amino-3-phenylpropionamido)-2-oxo-5-phenyl-8-methyl-2,3,4,5-tetrahydro-1H-1-benzazepin-1-yl]ethanoic acid amide
    ÏàËÆ¶È:56%
Journal of Medicinal Chemistry          1994          37          3789-3811
5-Phenyl-3-ureidobenzazepin-2-ones as Cholecystokinin-B Receptor Antagonists
John A. Lowe III, David L. Hageman, Susan E. Drozda, Stafford McLean, Dianne K. Bryce, Rosemary T. Crawford, Stevin Zorn, Jean Morrone, Jon Bordner
Structure      13C NMR   Ì¼Æ×Ä£Äâͼ
18 .     (S)-2-((S)-2-(N-((2'-(1H-Tetrazol-5-yl)biphenyl-4-yl)methyl)pentanamido)-3-methylbutanamido)propanoic acid
    ÏàËÆ¶È:56%
Archiv der Pharmazie          2012          345          393-400
Synthesis, Pharmacokinetics, and Pharmacodynamics Studies of Valsartan Peptide Derivatives
Chun Wu, Yanpeng Hu, Qianbin Li, Limei He, Jun Chen, Zeneng Cheng, Yuanjian Li and Gaoyun Hu
Structure      13C NMR   Ì¼Æ×Ä£Äâͼ
19 .     (R)-methyl 2-(2-((S)-2-(N-((2'-(1H-tetrazol-5-yl)biphenyl-4-yl)methyl)pentanamido)-3-methylbutanamido)acetamido)propanoate
    ÏàËÆ¶È:56%
Archiv der Pharmazie          2012          345          393-400
Synthesis, Pharmacokinetics, and Pharmacodynamics Studies of Valsartan Peptide Derivatives
Chun Wu, Yanpeng Hu, Qianbin Li, Limei He, Jun Chen, Zeneng Cheng, Yuanjian Li and Gaoyun Hu
Structure      13C NMR   Ì¼Æ×Ä£Äâͼ
Domyallbesttohaveahappylife.
4Â¥2013-06-28 14:52:46
ÒÑÔÄ   »Ø¸´´ËÂ¥   ¹Ø×¢TA ¸øTA·¢ÏûÏ¢ ËÍTAºì»¨ TAµÄ»ØÌû
Ïà¹Ø°æ¿éÌø×ª ÎÒÒª¶©ÔÄÂ¥Ö÷ 190824656 µÄÖ÷Ìâ¸üÐÂ
×î¾ßÈËÆøÈÈÌûÍÆ¼ö [²é¿´È«²¿] ×÷Õß »Ø/¿´ ×îºó·¢±í
[¿¼ÑÐ] 329Çóµ÷¼Á +3 ÏëÉÏѧ߹߹ 2026-03-19 3/150 2026-03-19 23:25 by fmesaito
[¿¼ÑÐ] 085600²ÄÁÏÓ뻯¹¤µ÷¼Á 324·Ö +10 llllkkkhh 2026-03-18 12/600 2026-03-19 14:33 by llllkkkhh
[¿¼ÑÐ] Çóµ÷¼Á +3 Mqqqqqq 2026-03-19 3/150 2026-03-19 14:11 by peike
[¿¼ÑÐ] 0703»¯Ñ§ 305Çóµ÷¼Á +4 FY_yy 2026-03-14 4/200 2026-03-19 05:54 by anny19840123
[¿¼ÑÐ] 085410È˹¤ÖÇÄÜר˶317Çóµ÷¼Á£¨0854¶¼¿ÉÒÔ£© +3 xbxudjdn 2026-03-18 3/150 2026-03-18 22:14 by zhq0425
[¿¼ÑÐ] 08¹¤¿Æ 320×Ü·Ö Çóµ÷¼Á +5 À滨çóÍí·ç 2026-03-17 5/250 2026-03-18 14:49 by haxia
[¿¼ÑÐ] 0854¿É¿çµ÷¼Á£¬Ò»×÷Ò»ÏîºËÐÄÂÛÎÄÎåÏîרÀû£¬Ê¡¡¢¹ú¼¶Ö¤Êé40+ÊýÒ»Ó¢Ò»287 +8 СÀî0854 2026-03-16 8/400 2026-03-18 14:35 by ²«»÷518
[¿¼ÑÐ] 298-Ò»Ö¾Ô¸Öйúũҵ´óѧ-Çóµ÷¼Á +7 ÊÖ»úÓû§ 2026-03-17 7/350 2026-03-18 14:34 by vgtyfty
[¿¼ÑÐ] 265Çóµ÷¼Á +3 ÁºÁºÐ£Ð£ 2026-03-17 3/150 2026-03-18 09:12 by zhukairuo
[¿¼ÑÐ] 334Çóµ÷¼Á +3 Ö¾´æ¸ßÔ¶ÒâÔÚ»úÐ 2026-03-16 3/150 2026-03-18 08:34 by lm4875102
[¿¼ÑÐ] 268Çóµ÷¼Á +8 Ò»¶¨ÓÐѧÉÏ- 2026-03-14 9/450 2026-03-17 17:47 by laoshidan
[¿¼ÑÐ] ¿¼Ñл¯Ñ§Ñ§Ë¶µ÷¼Á£¬Ò»Ö¾Ô¸985 +4 ÕÅvvvv 2026-03-15 6/300 2026-03-17 17:15 by ruiyingmiao
[¿¼ÑÐ] ²ÄÁÏÓ뻯¹¤×¨Ë¶µ÷¼Á +5 heming3743 2026-03-16 5/250 2026-03-17 14:03 by Ó¸ÒÌ«¼àÍõ¹«¹«
[¿¼²©] 26É격 +4 °Ë6°Ë68 2026-03-16 4/200 2026-03-17 13:00 by ÇáËɲ»ÉÙËæ
[¿¼ÑÐ] Ò»Ö¾Ô¸£¬¸£ÖÝ´óѧ²ÄÁÏר˶339·ÖÇóµ÷¼Á +3 ľ×ÓmomoÇàÕù 2026-03-15 3/150 2026-03-17 07:52 by laoshidan
[¿¼ÑÐ] 304Çóµ÷¼Á +3 ÂüÊâ2266 2026-03-14 3/150 2026-03-16 16:39 by houyaoxu
[¿¼ÑÐ] 0703Ò»Ö¾Ô¸211 285·ÖÇóµ÷¼Á +5 ly3471z 2026-03-13 5/250 2026-03-16 16:16 by ŶŶ123
[¿¼ÑÐ] 070303 ×Ü·Ö349Çóµ÷¼Á +3 LJY9966 2026-03-15 5/250 2026-03-16 14:24 by xwxstudy
[¿¼ÑÐ] Öпƴó²ÄÁÏר˶319Çóµ÷¼Á +3 ÃÏöβÄÁÏ 2026-03-13 3/150 2026-03-14 18:10 by houyaoxu
[¿¼ÑÐ] ÕÐÊÕ0805£¨²ÄÁÏ£©µ÷¼Á +3 18595523086 2026-03-13 3/150 2026-03-14 00:33 by 123%¡¢
ÐÅÏ¢Ìáʾ
ÇëÌî´¦ÀíÒâ¼û